Loading...
BeiGene, Ltd.
6160.HK•HKSE
Healthcare
Medical - Pharmaceuticals
HK$145.00
HK$0.00(0.00%)
BeiGene, Ltd. (6160.HK) Company Profile & Overview
Explore BeiGene, Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
BeiGene, Ltd. (6160.HK) Company Profile & Overview
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOJohn V. Oyler
Contact Information
Company Facts
11,000 Employees
IPO DateAug 8, 2018
CountryCN
Actively Trading